Table of Contents Author Guidelines Submit a Manuscript
PPAR Research
Volume 2015, Article ID 720383, 11 pages
http://dx.doi.org/10.1155/2015/720383
Research Article

Huaier Cream Protects against Adriamycin-Induced Nephropathy by Restoring Mitochondrial Function via PGC-1 Upregulation

1Department of Nephrology, Nanjing Children’s Hospital, Nanjing Medical University, 72 Guangzhou Road, Nanjing, Jiangsu 210029, China
2Institute of Pediatrics, Nanjing Medical University, Nanjing, Jiangsu 210008, China

Received 7 August 2014; Accepted 1 September 2014

Academic Editor: Yue Zhang

Copyright © 2015 Ruochen Che et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. A. Greenbaum, R. Benndorf, and W. E. Smoyer, “Childhood nephrotic syndrome-current and future therapies,” Nature Reviews Nephrology, vol. 8, no. 8, pp. 445–458, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. V. D. D'Agati, “The spectrum of focal segmental glomerulosclerosis: new insights,” Current Opinion in Nephrology and Hypertension, vol. 17, no. 3, pp. 271–281, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Fujinaga, A. Endo, Y. Ohtomo, Y. Ohtsuka, and T. Shimizu, “Uncertainty in management of childhood-onset idiopathic nephrotic syndrome: is the long-term prognosis really favorable?” Pediatric Nephrology, vol. 28, no. 12, pp. 2235–2238, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. I. A. Hauser, E. Schaeffeler, S. Gauer et al., “ABCB1 genotype of the donor but not of the recipient is a major risk factor for cyclosporine-related nephrotoxicity after renal transplantation,” Journal of the American Society of Nephrology, vol. 16, no. 5, pp. 1501–1511, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. R. C. Wiggins, “The spectrum of podocytopathies: a unifying view of glomerular diseases,” Kidney International, vol. 71, no. 12, pp. 1205–1214, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Chen, Z. Gong, X. Chen et al., “Tripterygium wilfordii Hook F (a traditional Chinese medicine) for primary nephrotic syndrome,” Cochrane Database of Systematic Reviews, vol. 8, Article ID CD008568, 2013. View at Google Scholar
  7. Y. Chen, Y. Deng, Z. Ni et al., “Efficacy and safety of traditional chinese medicine (Shenqi particle) for patients with idiopathic membranous nephropathy: a multicenter randomized controlled clinical trial,” American Journal of Kidney Diseases, vol. 62, no. 6, pp. 1068–1076, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Zhu, Y. Wang, M. Jardine et al., “Tripterygium preparations for the treatment of CKD: a systematic review and meta-analysis,” The American Journal of Kidney Diseases, vol. 62, no. 3, pp. 515–530, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. X.-P. Chen, S.-Q. He, X. Zhao, Z.-Y. Huang, and C.-H. Li, “Chinese medicine Extractum trametes robiniophila murr augment tumor necrosis factor related apoptosis-inducing ligand induced apoptosis in human hepatic cancer cell lines,” Zhonghua Wai Ke Za Zhi, vol. 43, no. 23, pp. 1524–1527, 2005. View at Google Scholar · View at Scopus
  10. C. Zhu, S. Huang, G. Ding et al., “Protective effects of Huang Qi Huai granules on adriamycin nephrosis in rats,” Pediatric Nephrology, vol. 26, no. 6, pp. 905–913, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. Ş. Güçer, B. Talim, E. Aşan et al., “Focal segmental glomerulosclerosis associated with mitochondrial cytopathy: report of two cases with special emphasis on podocytes,” Pediatric and Developmental Pathology, vol. 8, no. 6, pp. 710–717, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. W. Wang, Y. Wang, J. Long et al., “Mitochondrial fission triggered by hyperglycemia is mediated by ROCK1 activation in podocytes and endothelial cells,” Cell Metabolism, vol. 15, no. 2, pp. 186–200, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Su, A.-R. Dhoopun, Y. Yuan et al., “Mitochondrial dysfunction is an early event in aldosterone-induced podocyte injury,” The American Journal of Physiology—Renal Physiology, vol. 305, no. 4, pp. F520–F531, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Yuan, S. Huang, W. Wang et al., “Activation of peroxisome proliferator-activated receptor-γ coactivator 1α ameliorates mitochondrial dysfunction and protects podocytes from aldosterone-induced injury,” Kidney International, vol. 82, no. 7, pp. 771–789, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Zhu, X. Xuan, R. Che et al., “Dysfunction of the PGC-1α-mitochondria axis confers adriamycin-induced podocyte injury,” American Journal of Physiology—Renal Physiology, vol. 306, no. 12, pp. F1410–F1417, 2014. View at Publisher · View at Google Scholar
  16. V. W. Lee and D. C. Harris, “Adriamycin nephropathy: a model of focal segmental glomerulosclerosis,” Nephrology, vol. 16, no. 1, pp. 30–38, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Mundel, J. Reiser, and W. Kriz, “Induction of differentiation in cultured rat and human podocytes,” Journal of the American Society of Nephrology, vol. 8, no. 5, pp. 697–705, 1997. View at Google Scholar · View at Scopus
  18. S. Huang, A. Zhang, G. Ding, and R. Chen, “Aldosterone-induced mesangial cell proliferation is mediated by EGF receptor transactivation,” The American Journal of Physiology: Renal Physiology, vol. 296, no. 6, pp. F1323–F1333, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. B. M. Acton, A. Jurisicova, I. Jurisica, and R. F. Casper, “Alterations in mitochondrial membrane potential during preimplantation stages of mouse and human embryo development,” Molecular Human Reproduction, vol. 10, no. 1, pp. 23–32, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Galluzzi, O. Kepp, C. Trojel-Hansen, and G. Kroemer, “Mitochondrial control of cellular life, stress, and death,” Circulation Research, vol. 111, no. 9, pp. 1198–1207, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. Q. Zhang, K. Itagaki, and C. J. Hauser, “Mitochondrial DNA is released by shock and activates neutrophils via P38 map kinase,” Shock, vol. 34, no. 1, pp. 55–59, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Bertani, A. Poggi, R. Pozzoni et al., “Adriamycin-induced nephrotic syndrome in rats. Sequence of pathologic events,” Laboratory Investigation, vol. 46, no. 1, pp. 16–23, 1982. View at Google Scholar · View at Scopus
  23. T. S. Lahoti, D. Patel, V. Thekkemadom, R. Beckett, and S. D. Ray, “Doxorubicin-induced in vivo nephrotoxicity involves oxidative stress-mediated multiple pro- and anti-apoptotic signaling pathways,” Current Neurovascular Research, vol. 9, no. 4, pp. 282–295, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. R. S. Balaban, S. Nemoto, and T. Finkel, “Mitochondria, oxidants, and aging,” Cell, vol. 120, no. 4, pp. 483–495, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. V. Temkin, Q. Huang, H. Liu, H. Osada, and R. M. Pope, “Inhibition of ADP/ATP exchange in receptor-interacting protein-mediated necrosis,” Molecular and Cellular Biology, vol. 26, no. 6, pp. 2215–2225, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Kanki and D. J. Klionsky, “The molecular mechanism of mitochondria autophagy in yeast,” Molecular Microbiology, vol. 75, no. 4, pp. 795–800, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. P. J. Adhihetty, G. Uguccioni, L. Leick, J. Hidalgo, H. Pilegaard, and D. A. Hood, “The role of PGC-1α on mitochondrial function and apoptotic susceptibility in muscle,” The American Journal of Physiology—Cell Physiology, vol. 297, no. 1, pp. C217–C225, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. Z. Lu, X. Xu, X. Hu et al., “PGC-1α regulates expression of myocardial mitochondrial antioxidants and myocardial oxidative stress after chronic systolic overload,” Antioxidants and Redox Signaling, vol. 13, no. 7, pp. 1011–1022, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. R. R. Thomas, S. M. Kha, R. M. Smigrodzki et al., “RhTFAM treatment stimulates mitochondrial oxidative metabolism and improves memory in aged mice,” Aging, vol. 4, no. 9, pp. 620–635, 2012. View at Google Scholar · View at Scopus
  30. P. J. Fernandez-Marcos and J. Auwerx, “Regulation of PGC-1α, a nodal regulator of mitochondrial biogenesis,” The American Journal of Clinical Nutrition, vol. 93, no. 4, pp. 884S–890S, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. C. Zhu, S. Huang, Y. Yuan et al., “Mitochondrial dysfunction mediates aldosterone-induced podocyte damage: a therapeutic target of PPARγ,” The American Journal of Pathology, vol. 178, no. 5, pp. 2020–2031, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Tsuruoka, A. Hiwatashi, J. Usui, and K. Yamagata, “The mitochondrial SIRT1-PGC-1α axis in podocyte injury,” Kidney International, vol. 82, no. 7, pp. 735–736, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Matsumura, A. Ashida, K. Hirano, H. Nakakura, and H. Tamai, “Protective effect of radical scavenger edaravone against puromycin nephrosis,” Clinical Nephrology, vol. 66, no. 6, pp. 405–410, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. H. S. Lee, J. Y. Jeong, B. C. Kim, Y. S. Kim, Y. Z. Zhang, and H. K. Chung, “Dietary antioxidant inhibits lipoprotein oxidation and renal injury in experimental focal segmental glomerulosclerosis,” Kidney International, vol. 51, no. 4, pp. 1151–1159, 1997. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Tahzib, R. Frank, B. Gauthier, E. Valderrama, and H. Trachtman, “Vitamin E treatment of focal segmental glomerulosclerosis: results of an open-label study,” Pediatric Nephrology, vol. 13, no. 8, pp. 649–652, 1999. View at Publisher · View at Google Scholar · View at Scopus
  36. X. Wang, N. Zhang, Q. Huo, and Q. Yang, “Anti-angiogenic and antitumor activities of Huaier aqueous extract,” Oncology Reports, vol. 28, no. 4, pp. 1167–1175, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. N. Zhang, X. Kong, S. Yan, C. Yuan, and Q. Yang, “Huaier aqueous extract inhibits proliferation of breast cancer cells by inducing apoptosis,” Cancer Science, vol. 101, no. 11, pp. 2375–2383, 2010. View at Publisher · View at Google Scholar · View at Scopus